PACS Group (PACS) Competitors $10.91 -0.14 (-1.27%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$10.78 -0.13 (-1.15%) As of 03/28/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACS vs. OPCH, GH, RDNT, SHC, BTSG, SGRY, WGS, PRVA, CON, and LFSTShould you be buying PACS Group stock or one of its competitors? The main competitors of PACS Group include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry. PACS Group vs. Option Care Health Guardant Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Privia Health Group Concentra Group Holdings Parent LifeStance Health Group PACS Group (NYSE:PACS) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, community ranking, media sentiment, earnings and analyst recommendations. Does the media refer more to PACS or OPCH? In the previous week, Option Care Health had 5 more articles in the media than PACS Group. MarketBeat recorded 14 mentions for Option Care Health and 9 mentions for PACS Group. Option Care Health's average media sentiment score of 1.58 beat PACS Group's score of 0.46 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 5 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Option Care Health 11 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is PACS or OPCH more profitable? Option Care Health has a net margin of 4.37% compared to PACS Group's net margin of 0.00%. Option Care Health's return on equity of 15.30% beat PACS Group's return on equity.Company Net Margins Return on Equity Return on Assets PACS GroupN/A N/A N/A Option Care Health 4.37%15.30%6.57% Do insiders & institutionals believe in PACS or OPCH? 98.1% of Option Care Health shares are owned by institutional investors. 0.6% of Option Care Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PACS or OPCH? Option Care Health received 37 more outperform votes than PACS Group when rated by MarketBeat users. However, 95.83% of users gave PACS Group an outperform vote while only 62.50% of users gave Option Care Health an outperform vote. CompanyUnderperformOutperformPACS GroupOutperform Votes2395.83% Underperform Votes14.17%Option Care HealthOutperform Votes6062.50% Underperform Votes3637.50% Do analysts rate PACS or OPCH? PACS Group presently has a consensus price target of $34.00, indicating a potential upside of 211.64%. Option Care Health has a consensus price target of $33.00, indicating a potential downside of 4.98%. Given PACS Group's stronger consensus rating and higher probable upside, research analysts clearly believe PACS Group is more favorable than Option Care Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88Option Care Health 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has higher earnings and valuation, PACS or OPCH? Option Care Health has higher revenue and earnings than PACS Group. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPACS Group$3.56B0.47$112.87MN/AN/AOption Care Health$5.00B1.14$267.09M$1.2228.47 SummaryOption Care Health beats PACS Group on 11 of the 15 factors compared between the two stocks. Remove Ads Get PACS Group News Delivered to You Automatically Sign up to receive the latest news and ratings for PACS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PACS vs. The Competition Export to ExcelMetricPACS GroupSkilled nursing care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$1.66B$2.11B$5.63B$19.40BDividend YieldN/A1.43%5.33%3.75%P/E RatioN/A12.9623.5333.04Price / Sales0.470.86388.1926.59Price / CashN/A12.2638.1717.55Price / BookN/A2.796.894.53Net Income$112.87M$120.70M$3.20B$1.02B7 Day Performance-5.41%-0.79%-3.06%-1.30%1 Month Performance-16.15%-4.32%1.51%-4.04%1 Year PerformanceN/A1.74%9.35%2.59% PACS Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PACSPACS Group3.8336 of 5 stars$10.91-1.3%$34.00+211.6%N/A$1.66B$3.56B0.0032,433Options VolumeNews CoverageOPCHOption Care Health3.9079 of 5 stars$34.71+0.4%$33.00-4.9%+3.5%$5.74B$5.00B29.175,600Positive NewsGHGuardant Health4.1762 of 5 stars$46.74+1.4%$48.40+3.6%+109.1%$5.69B$739.02M-13.131,790Analyst ForecastNews CoveragePositive NewsRDNTRadNet3.8187 of 5 stars$51.83+5.2%$73.25+41.3%+1.6%$3.84B$1.83B-740.328,970SHCSotera Health2.646 of 5 stars$12.21+2.6%$15.92+30.4%-2.0%$3.46B$1.10B48.843,000BTSGBrightSpring Health Services2.7393 of 5 stars$18.69+3.5%$21.67+15.9%+65.9%$3.27B$11.27B-71.8835,000Gap UpSGRYSurgery Partners2.8128 of 5 stars$24.39+0.7%$36.63+50.2%-19.7%$3.11B$3.11B-50.8113,500Analyst ForecastWGSGeneDx2.1175 of 5 stars$103.19-1.1%$72.33-29.9%+909.9%$2.90B$305.45M-52.651,200Insider TradeGap UpPRVAPrivia Health Group3.3192 of 5 stars$23.92+2.5%$26.67+11.5%+15.3%$2.88B$1.74B239.221,102Positive NewsCONConcentra Group Holdings ParentN/A$21.49+3.2%$28.50+32.6%N/A$2.74B$1.90B14.2311,000Positive NewsLFSTLifeStance Health Group2.5456 of 5 stars$6.76-1.3%$8.63+27.6%+8.6%$2.60B$1.25B-26.009,325Positive News Remove Ads Related Companies and Tools Related Companies OPCH Alternatives GH Alternatives RDNT Alternatives SHC Alternatives BTSG Alternatives SGRY Alternatives WGS Alternatives PRVA Alternatives CON Alternatives LFST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PACS) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PACS Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PACS Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
